These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 18613766)

  • 1. Approved monoclonal antibodies for cancer therapy.
    Boyiadzis M; Foon KA
    Expert Opin Biol Ther; 2008 Aug; 8(8):1151-8. PubMed ID: 18613766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of rituximab, the new FDA-approved antibody.
    Leget GA; Czuczman MS
    Curr Opin Oncol; 1998 Nov; 10(6):548-51. PubMed ID: 9818234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies as targeted therapy in hematologic malignancies in older adults.
    Rao AV; Schmader K
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):247-62. PubMed ID: 17996665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newer monoclonal antibodies for hematological malignancies.
    Castillo J; Winer E; Quesenberry P
    Exp Hematol; 2008 Jul; 36(7):755-68. PubMed ID: 18565392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-drug conjugates: an emerging modality for the treatment of cancer.
    Leal M; Sapra P; Hurvitz SA; Senter P; Wahl A; Schutten M; Shah DK; Haddish-Berhane N; Kabbarah O
    Ann N Y Acad Sci; 2014 Aug; 1321():41-54. PubMed ID: 25123209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody therapies for solid tumors.
    Tassev DV; Cheung NK
    Expert Opin Biol Ther; 2009 Mar; 9(3):341-53. PubMed ID: 19216623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iodine-131 Tositumomab: (131)I-anti-B1 antibody, (131)I-tositumomab, anti-CD20 murine monoclonal antibody-I-131, B1, Bexxar, (131)I-anti-B1 antibody, iodine-131 tositumomab, iodine-131 anti-B1 antibody, tositumomab.
    BioDrugs; 2003; 17(4):290-5. PubMed ID: 12899647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab: ongoing and future clinical development.
    Grillo-López AJ; Hedrick E; Rashford M; Benyunes M
    Semin Oncol; 2002 Feb; 29(1 Suppl 2):105-12. PubMed ID: 11842397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bendamustine for the treatment of chronic lymphocytic leukemia and rituximab-refractory, indolent B-cell non-Hodgkin lymphoma.
    Dennie TW; Kolesar JM
    Clin Ther; 2009; 31 Pt 2():2290-311. PubMed ID: 20110042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic additions and possible deletions in oncology in 2011.
    Holstein SA; Hohl RJ
    Clin Pharmacol Ther; 2012 Jan; 91(1):15-7. PubMed ID: 22179625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rituximab, a chimeric anti-CD20 monoclonal antibody, in the treatment of B-cell lymphoma].
    Tobinai K
    Gan To Kagaku Ryoho; 2002 Mar; 29(3):473-80. PubMed ID: 11915743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic monoclonal antibodies: trends in development and approval in the US.
    Reichert JM
    Curr Opin Mol Ther; 2002 Apr; 4(2):110-8. PubMed ID: 12044031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA approves new kind of lymphoma treatment. Food and Drug Administration.
    James JS; Dubs G
    AIDS Treat News; 1997 Dec; (No 284):2-3. PubMed ID: 11364912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody approved for metastatic breast cancer.
    Oncology (Williston Park); 1998 Dec; 12(12):1727. PubMed ID: 9874846
    [No Abstract]   [Full Text] [Related]  

  • 15. [Monoclonal antibody for cancer treatment].
    Achiwa H; Sato S; Ueda R
    Gan To Kagaku Ryoho; 2002 Apr; 29(4):495-501. PubMed ID: 11977531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibody therapy.
    O'Mahony D; Bishop MR
    Front Biosci; 2006 May; 11():1620-35. PubMed ID: 16368542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical status and optimal use of rituximab for B-cell lymphomas.
    McLaughlin P; White CA; Grillo-López AJ; Maloney DG
    Oncology (Williston Park); 1998 Dec; 12(12):1763-9; discussion 1769-70, 1775-7,. PubMed ID: 9874849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dinutuximab approved for high-risk neuroblastoma.
    Cancer Discov; 2015 Jun; 5(6):OF5. PubMed ID: 25851859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-targeted immunotherapy for treatment of malignancy.
    White CA; Weaver RL; Grillo-López AJ
    Annu Rev Med; 2001; 52():125-45. PubMed ID: 11160771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of ramucirumab in the treatment of cancer - A review of literature.
    Vennepureddy A; Singh P; Rastogi R; Atallah JP; Terjanian T
    J Oncol Pharm Pract; 2017 Oct; 23(7):525-539. PubMed ID: 27306885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.